peptideone
← All peptides

Albiglutide

Status unknown

Also known as: albiglutidum, Albiglutida, RefChem:141, A10BJ04, Albiglutide (genetical recombination), 5E7U48495E, 782500-75-8, Eperzan

Albiglutide (albiglutidum, Albiglutida, RefChem:141) is classified under glp-1 & incretin agonists.

Independent test grades

No independent third-party test data is available for Albiglutide yet. Our test grades are aggregated from Finnrick, which independently tests a subset of research peptides — many approved drugs and newer or niche compounds aren't covered.

Research literature (8)

Consolidated from PubMed — each links to the original record.

FAQ

What is Albiglutide?
Albiglutide (albiglutidum, Albiglutida, RefChem:141) is classified under glp-1 & incretin agonists. Research goals associated with it include metabolic & weight.
Is Albiglutide FDA-approved?
The regulatory status of Albiglutide is not established in our sources.
What does the research on Albiglutide say?
peptideone aggregates 8 references from PubMed for Albiglutide. The summary on this page digests them with citations; we summarize sources and make no efficacy claims.
Aggregated from public sources, with attribution. Not medical advice; compounds discussed are not approved for human consumption. Last updated 2026-06-15.